PONTES JOSIAS (VP, Head of Finance) reported 1 transaction at SIGILON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/11/2023ACC: 0001415889-23-012126
Officer· VP, Head of Finance
Since Jun 2021
-14.27K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
14.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.50K
Price / share
—
Trade value
—
% of position
New position
8/11/2023
3.50K→0.00
Total
Net shares
−3.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2023 | D · Disposition | −3.50K | — | — | New position | 3.50K | 0.00 |
| Total | −3.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10.77K shares
Shares
−10.77K
Strike price
14.17
Held after
0.00
Exercisable
—
8/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10.77K shares | 8/11/2023 | D · Disposition | −10.77K | 14.17 | — | 0.00 |